Singapore: Australia's Allied Healthcare's CardioCel tissue patches has shown superiority for stem cells survival and gr...
Singapore: Australia-based specialty pharmaceutical company Hatchtech published data describing the mechanism of action ...
Singapore: Phylogica has agreed to raise $1.6 million of new capital through a placement of 16,000 unlisted converting n...
Singapore: University of Queensland (UQ) has secured support from the federal government for two research of its project...
Singapore: Quest PharmaTech, a pharmaceutical company developing and commercializing products for the treatment of cance...
Singapore: Genetic Technologies revealed that a story highlighting the BREVAGen test and its successful US launch featur...
Singapore: A recent report presented by Frost & Sullivan has said that the healthcare industry in Asia Pacific is em...
Singapore: Starpharma's vice president, Dr Malcolm McColl, has been appointed CEO, Viralytics. Prior to this, Dr McCol...
Singapore: Bluechiip, which has developed a unique temperature sensing and tracking solution initially for cryogenic sa...
Singapore: HeartWare International, a leading innovator of less invasive, miniaturized circulatory support technologies...
Singapore: Bionomics has been advised by its licensee, Ironwood Pharmaceuticals, that following the submission of an In...
Singapore: Australia's Therapeutic Goods Administration (TGA) has identified errors in its internal reports regarding t...
Singapore: Australia-based Telesso Technologies raised $6.5 million capital in connection with its acquisition of Mimeti...
Singapore: South Korea is the fourth largest contributor to the lifescience market in the region. • Korean Minis...
Singapore: The number of Australians with age-related macular degeneration (AMD) is expected to grow to over 1.7 million...
Singapore: Australian drug discovery firm, Bionomics, has received positive results in the phase I clinical trial of its...
Singapore: Australia-based Viralytics in its ongoing US-based phase II melanoma trial of its virotherapy candidate Cava...
Singapore: NovaBay Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class non-antibiotic, ant...
